Stefania Redana
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Journal: Breast (Edinburgh, Scotland)
Published: June 12, 2017
Reduced Rates of Severe Complications Following a Change in Anthracycline-Taxane Regimen for Early Breast Cancer: a Single Centre Experience.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 30, 2016
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.
Journal: Breast (Edinburgh, Scotland)
Published: April 28, 2016
Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 24, 2015
Metastatic breast cancer subtypes and central nervous system metastases.
Journal: Breast (Edinburgh, Scotland)
Published: January 31, 2014
FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer.
Journal: Clinical nuclear medicine
Published: January 09, 2014
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Journal: Breast (Edinburgh, Scotland)
Published: April 22, 2013
Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.
Journal: The oncologist
Published: September 07, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026